Dermfree Scar Sheets Patch
NDC Package 85248-110-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Dermfree Scar Sheets (silicone gel 1% scar sheets) patches is use this product once scar or wound has healed for at least 7 days, You may start using immediately on older scars, For old scars, the product can be used immediately. This formulation utilizes a patch delivery system. Marketed by Jiangxi Yudexi Pharmaceutical Co., Ltd, this product is identified by NDC 85248-110 and is authorized under FDA application M016.

Identification & Billing

NDC Package Code
85248-110-01
Package Description
36.2 g in 1 BOX
Product Code
85248-110
11-Digit Billing Format
85248011001

Clinical Specifications

Proprietary Name
Dermfree Scar Sheets
Non-Proprietary Name
Silicone Gel 1% Scar Sheets
Substance Name
Cyclomethicone
Dosage Form
Patch - A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms ‘extended release film’ and ‘system’.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
CYCLOMETHICONE 1 g/100g
Usage Information
Use this product once scar or wound has healed for at least 7 days, You may start using immediately on older scars, For old scars, the product can be used immediately. Do not use on unhealed wounds.infected areas. or acne-prone skin. If applied to unclean skin or worn too tightly, it may cause skin irritation or rashes. If this occurs, reduce wear time and ensure proper application. it should be reduced to stick and stick for less time. Dosage and administration For external use only.

Regulatory & Marketing

Labeler Name
Jiangxi Yudexi Pharmaceutical Co., Ltd
Product Type
Human Otc Drug
FDA Application #
M016
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-08-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85248-110-01 identifies a specific commercial package of 36.2 g in 1 box of Dermfree Scar Sheets, a human over the counter drug labeled by Jiangxi Yudexi Pharmaceutical Co., Ltd. This patch is formulated for topical use and contains cyclomethicone as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Jiangxi Yudexi Pharmaceutical Co., Ltd on February 08, 2026. The current certification is valid through December 31, 2027.

How is this Jiangxi Yudexi Pharmaceutical Co., Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85248011001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85248-110-01
11-Digit CMS (5-4-2)
85248-0110-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.